Microbix Biosystems Inc.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays… Read more
Microbix Biosystems Inc. (MBXBF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.003x
Based on the latest financial reports, Microbix Biosystems Inc. (MBXBF) has a cash flow conversion efficiency ratio of 0.003x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($83.95K) by net assets ($27.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Microbix Biosystems Inc. - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Microbix Biosystems Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Microbix Biosystems Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Microbix Biosystems Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SUPPLY ME CAP. LS -00002
F:IE6B
|
N/A |
|
CammSys Corp
KQ:050110
|
0.139x |
|
DevvStream Holdings Inc.
OTCQB:DSTRF
|
0.071x |
|
Shree Rama Multi-Tech Limited
NSE:SHREERAMA
|
0.161x |
|
LQwD FinTech Corp
OTCQX:LQWDF
|
-0.022x |
|
Cokal Ltd
AU:CKA
|
0.410x |
|
Onward Technologies Limited
NSE:ONWARDTEC
|
0.151x |
|
Heubach Colorants India Limited
NSE:HEUBACHIND
|
N/A |
Annual Cash Flow Conversion Efficiency for Microbix Biosystems Inc. (2000–2025)
The table below shows the annual cash flow conversion efficiency of Microbix Biosystems Inc. from 2000 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $27.79 Million | $-80.29K | -0.003x | -101.88% |
| 2024-09-30 | $28.30 Million | $4.35 Million | 0.154x | +445.65% |
| 2023-09-30 | $24.62 Million | $-1.09 Million | -0.044x | -131.99% |
| 2022-09-30 | $24.94 Million | $3.47 Million | 0.139x | +22.39% |
| 2021-09-30 | $18.56 Million | $2.11 Million | 0.114x | +8673.40% |
| 2020-09-30 | $6.62 Million | $8.57K | 0.001x | -69.27% |
| 2019-09-30 | $10.54 Million | $44.37K | 0.004x | +108.12% |
| 2018-09-30 | $10.35 Million | $-537.00K | -0.052x | -364.96% |
| 2017-09-30 | $15.17 Million | $297.05K | 0.020x | -67.22% |
| 2016-09-30 | $15.29 Million | $913.31K | 0.060x | +37.19% |
| 2015-09-30 | $13.68 Million | $595.40K | 0.044x | +136.59% |
| 2014-09-30 | $8.79 Million | $-1.05 Million | -0.119x | -259.02% |
| 2013-09-30 | $5.55 Million | $415.13K | 0.075x | -- |
| 2012-09-30 | $4.20 Million | $0.00 | 0.000x | -- |
| 2011-09-30 | $4.90 Million | $0.00 | 0.000x | -- |
| 2010-09-30 | $5.49 Million | $0.00 | 0.000x | -- |
| 2009-09-30 | $6.00 Million | $0.00 | 0.000x | -- |
| 2008-09-30 | $7.16 Million | $0.00 | 0.000x | -- |
| 2007-09-30 | $2.30 Million | $0.00 | 0.000x | -- |
| 2006-09-30 | $1.32 Million | $0.00 | 0.000x | -- |
| 2005-09-30 | $2.38 Million | $319.78K | 0.134x | -31.02% |
| 2004-09-30 | $1.81 Million | $352.59K | 0.195x | -- |
| 2003-09-30 | $1.47 Million | $0.00 | 0.000x | -- |
| 2002-09-30 | $1.33 Million | $66.80K | 0.050x | -71.03% |
| 2001-09-30 | $1.30 Million | $225.15K | 0.173x | -- |
| 2000-09-30 | $1.17 Million | $0.00 | 0.000x | -- |